Na Qu

1.7k total citations
56 papers, 754 citations indexed

About

Na Qu is a scholar working on Molecular Biology, Oncology and Psychiatry and Mental health. According to data from OpenAlex, Na Qu has authored 56 papers receiving a total of 754 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 10 papers in Oncology and 8 papers in Psychiatry and Mental health. Recurrent topics in Na Qu's work include Cancer, Stress, Anesthesia, and Immune Response (8 papers), Neuropeptides and Animal Physiology (5 papers) and Autophagy in Disease and Therapy (5 papers). Na Qu is often cited by papers focused on Cancer, Stress, Anesthesia, and Immune Response (8 papers), Neuropeptides and Animal Physiology (5 papers) and Autophagy in Disease and Therapy (5 papers). Na Qu collaborates with scholars based in China, United States and Canada. Na Qu's co-authors include Lesheng Teng, Congying Wang, Ming Zhang, Yating Sun, Ben‐Zhan Zhu, Chengxia Kan, Xiaodong Sun, Liang‐Hong Guo, Fengping Shan and Ningning Hou and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Biomaterials.

In The Last Decade

Na Qu

54 papers receiving 740 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Na Qu China 14 365 141 111 94 92 56 754
Patricia García‐López Mexico 20 469 1.3× 135 1.0× 137 1.2× 136 1.4× 191 2.1× 54 1.1k
Yi Ma China 16 370 1.0× 117 0.8× 137 1.2× 315 3.4× 103 1.1× 44 858
Yaxin Lu China 16 273 0.7× 71 0.5× 140 1.3× 69 0.7× 59 0.6× 48 712
Mengyu Chen China 17 433 1.2× 192 1.4× 138 1.2× 221 2.4× 61 0.7× 60 935
Yi‐Chun Chen Taiwan 17 436 1.2× 51 0.4× 66 0.6× 80 0.9× 46 0.5× 50 869
Sarah Giacometti France 14 296 0.8× 94 0.7× 90 0.8× 95 1.0× 259 2.8× 25 690
Arianna Bonizzi Italy 16 354 1.0× 195 1.4× 90 0.8× 264 2.8× 236 2.6× 39 875
Hongyan Cui China 20 521 1.4× 81 0.6× 176 1.6× 233 2.5× 119 1.3× 55 1.1k
Zihui Yang China 19 277 0.8× 35 0.2× 91 0.8× 122 1.3× 119 1.3× 65 990

Countries citing papers authored by Na Qu

Since Specialization
Citations

This map shows the geographic impact of Na Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Na Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Na Qu more than expected).

Fields of papers citing papers by Na Qu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Na Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Na Qu. The network helps show where Na Qu may publish in the future.

Co-authorship network of co-authors of Na Qu

This figure shows the co-authorship network connecting the top 25 collaborators of Na Qu. A scholar is included among the top collaborators of Na Qu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Na Qu. Na Qu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Gang, Ruixue Yang, Qianming Chen, et al.. (2025). Activation of PERK/eIF2α/ATF4 signaling inhibits ERα expression in breast cancer. Neoplasia. 65. 101165–101165.
2.
Fan, Zihao, et al.. (2024). LncRNA taurine upregulated gene 1 in liver disease. Clinica Chimica Acta. 560. 119752–119752. 1 indexed citations
3.
Qu, Na, et al.. (2024). INPP4B suppresses HER2-induced mesenchymal transition in HER2+ breast cancer and enhances sensitivity to Lapatinib. Biochemical Pharmacology. 226. 116347–116347. 2 indexed citations
4.
Wang, Gang, et al.. (2024). TCF12-regulated GRB7 facilitates the HER2+ breast cancer progression by activating Notch1 signaling pathway. Journal of Translational Medicine. 22(1). 745–745. 5 indexed citations
5.
Yu, Xiaoping, Bo Chen, Gang Wang, et al.. (2024). CCT020312 exerts anti-prostate cancer effect by inducing G1 cell cycle arrest, apoptosis and autophagy through activation of PERK/eIF2α/ATF4/CHOP signaling. Biochemical Pharmacology. 221. 116038–116038. 5 indexed citations
6.
Qu, Na, et al.. (2024). Bevacizumab increases cisplatin efficacy by inhibiting epithelial–mesenchymal transition via ALDH1 in cervical carcinoma. International Immunopharmacology. 145. 113736–113736. 2 indexed citations
7.
Qu, Na, Yiming Meng, Jingbo Zhai, et al.. (2023). Methionine enkephalin inhibited cervical cancer migration as well as invasion and activated CD11b+ NCR1+ NKs of tumor microenvironment. International Immunopharmacology. 124(Pt B). 110967–110967. 2 indexed citations
8.
Qu, Na, et al.. (2023). The function of long non-coding RNA in non-alcoholic fatty liver disease. Clinics and Research in Hepatology and Gastroenterology. 47(3). 102095–102095. 5 indexed citations
9.
10.
Chen, Bo, et al.. (2023). VPS34-IN1 induces apoptosis of ER+ breast cancer cells via activating PERK/ATF4/CHOP pathway. Biochemical Pharmacology. 214. 115634–115634. 8 indexed citations
11.
Qu, Na, et al.. (2022). Retinoic Acid Promotes the In Vitro Growth, Patterning and Improves the Cellular Composition of Human Pluripotent Stem-Cell-Derived Intestinal Organoids. International Journal of Molecular Sciences. 23(15). 8624–8624. 1 indexed citations
12.
Li, Xue, Xiaodong Sun, Chengxia Kan, et al.. (2022). COL1A1: A novel oncogenic gene and therapeutic target in malignancies. Pathology - Research and Practice. 236. 154013–154013. 62 indexed citations
13.
Ma, Yuting, Guangdong Zhang, Qian Xu, et al.. (2022). Empagliflozin activates Sestrin2-mediated AMPK/mTOR pathway and ameliorates lipid accumulation in obesity-related nonalcoholic fatty liver disease. Frontiers in Pharmacology. 13. 944886–944886. 21 indexed citations
14.
Qu, Na, Ruizhe Wang, Yiming Meng, et al.. (2022). Methionine enkephalin inhibited cervical carcinoma via apoptosis promotion and reduction of myeloid derived suppressor cell infiltrated in tumor. International Immunopharmacology. 110. 108933–108933. 6 indexed citations
15.
Huang, Hai, et al.. (2021). Research progress of opioid growth factor in immune-related diseases and cancer diseases. International Immunopharmacology. 99. 107713–107713. 8 indexed citations
16.
Cao, Xia, et al.. (2021). Methionine enkephalin activates autophagy and stimulates tumour cell immunogenicity in human cutaneous squamous cell carcinoma. International Immunopharmacology. 96. 107733–107733. 9 indexed citations
17.
Bai, Xueli, Fengping Shan, Na Qu, et al.. (2021). Regulatory role of methionine enkephalin in myeloid-derived suppressor cells and macrophages in human cutaneous squamous cell carcinoma. International Immunopharmacology. 99. 107996–107996. 8 indexed citations
18.
Meng, Yiming, Jing Sun, Na Qu, et al.. (2019). <p>Application of Radiomics for Personalized Treatment of Cancer Patients</p>. Cancer Management and Research. Volume 11. 10851–10858. 27 indexed citations
19.
Zhang, Ming, et al.. (2018). Long noncoding RNA lncARSR promotes hepatic lipogenesis via Akt/SREBP-1c pathway and contributes to the pathogenesis of nonalcoholic steatohepatitis. Biochemical and Biophysical Research Communications. 499(1). 66–70. 72 indexed citations
20.
Qu, Na, Yating Sun, Jing Xie, & Lesheng Teng. (2016). Preparation and Evaluation of in vitro Self-assembling HSA Nanoparticles for Cabazitaxel. Anti-Cancer Agents in Medicinal Chemistry. 17(2). 294–300. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patricia García‐López Breakdown of academic impact, for papers by Yi Ma Breakdown of academic impact, for papers by Yaxin Lu Breakdown of academic impact, for papers by Mengyu Chen Breakdown of academic impact, for papers by Yi‐Chun Chen Breakdown of academic impact, for papers by Sarah Giacometti Breakdown of academic impact, for papers by Arianna Bonizzi Breakdown of academic impact, for papers by Hongyan Cui Breakdown of academic impact, for papers by Zihui Yang
Rankless by CCL
2026